The Allan Frenkel Foundation supports patients and carers with $42,000 donation
The Allan Frenkel Foundation has brought comfort to patients and their carers in their time of need by funding vital support services for over two decades. Over the past 21 years, the Foundation has supported a clinical trial for PUVA wands to alleviate pain from mouth ulceration, contributed to the new bone marrow transplant ward […]
The history of the Hawkesbury Canoe Classic (HCC) and Arrow partnership uncovered
As relatively new staff members, we’ve often wondered how and when the tremendous partnership between the HCC and Arrow began. And last week, whilst looking through some old files, we were lucky enough to unearth some solid evidence. The HCC first paddled for Arrow (then named The Australian Bone Marrow Transplant Foundation) in 1993, to […]
Arrow / HCC PhD scholarship awarded to Natalia Pinello
We are pleased to award Arrow / HCC scholarship funding to Natalia Pinello from The Centenary Institute, providing approximately $13,000 per year towards her PhD project until 2021. Natalia wrote: The DNA in all of the cells in our body control what each cell looks like and all of its specific functions. This is because […]
Exceptional clinical nursing care
“Provides exceptional evidence based clinical nursing care to patients and families, and in a short timeframe has quickly become a leader and a very valued member of staff” is how Ide Irwin’s Nurse Unit Manager at St Vincent’s Hospital in Sydney describes her. Ide Irwin has been employed as a full time Registered Nurse on […]
Arrow and the Hawkesbury Canoe Classic (HCC) fund targeted therapies
The vital work of Arrow / HCC research scientist, Dr Tim Molloy, and projects undertaken by Arrow / HCC PhD scholarship students will continue to improve treatments for bone marrow transplant patients thanks to a $93,000 donation from Arrow’s major supporter, the Hawkesbury Canoe Classic (HCC). Dr Tim Molloy said: “Having the support of Arrow […]
Belinda shares the story behind her brother’s bequest
My brother, Marcus Shepherd, was diagnosed with Acute Myeloid Leukaemia (AML) in 1982 (age 32). He had his initial chemotherapy and went into remission in New Zealand, prior to further evaluation and consultation at St Vincent’s Hospital, Sydney. Luckily, I matched his tissue and blood type and Marcus had a bone marrow transplant under Professor […]
It’s in giving that we receive
When Michael Quigley, a retired telecommunications engineer and CEO of NBN Co. for its first four years, re-joined the Arrow board – it was to take on a new challenge. After a successful 35-year career in the global telecommunications industry Michael is no stranger to problem solving, a skill that’s essential for the ongoing success […]
The Arrow Bone Marrow Transplant Patient Room launches
Arrow Chairman, Mark O’Hara, and CEO Robyn Flood attended the official opening of the St Vincent’s Haematology, Blood and Marrow Transplant Unit on behalf of the many Arrow supporters who helped Arrow raise the $300,000 needed to fund a room that is specially designed to improve infection control and provide greater comfort for patients during […]
Record donation of $1 million to Arrow for Stem Cell Transplantation research
Arrow is pleased to announce that Vicki and Michael Quigley have donated $1 million to Arrow to support the research work of Professor David Ma, Department of Haematology and Bone Marrow Transplant, St Vincent’s Hospital, Sydney. When Arrow was established 30 years ago, bone marrow transplants were only suitable for a limited numbers of patients […]
Allan Frenkel Foundation celebrates 20-year milestone
A year after losing Allan to Acute Lymphatic Leukaemia, his family hosted a dinner to raise funds for teens with cancer, with a focus on patient support. The Allan Frenkel Foundation has since held a fundraising dinner in Allan’s memory every year, and this year we join them in celebrating 20 years of raising vital […]
Latest Arrow/HCC achievements in research
Arrow/HCC Research Scientist 2017 report In 2017 Dr Melinda Tursky continued her research in targeting genes which drive the progression from normal to cancerous blood cells in the Blood Stem Cell and Cancer Research Programme, St Vincent’s Centre for Applied Medical Research. During this period, Melinda’s work focused on discovering therapeutic potential of specific inhibitors […]